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Editorial: Dietary Lipid Absorption 
The composition of dietary fat influences tissue fatty acid composi-
tion, which in turn impacts cellular function through a number of 
different processes. This includes changes in signaling, lipid metab-
olism, and transcriptional activities that normally function to main-
tain intracellular fatty acid homeostasis. The consumption of high 
levels of dietary fat in excess of caloric expenditure is linked with 
obesity and the disruption of normal homeostatic mechanisms gov-
erning lipid metabolism. Data from the Centers for Disease Control 
and Prevention show that obesity (defined as a BMI≥30) represents 
a considerable health concern in the United States. Of particular note 
is that for adult men, the prevalence of obesity was 33% in 2006; 
the prevalence for adult women was slightly higher at 35%. Obesity 
is also of concern for children and adolescents where in 2006, 16% 
were considered obese (above the 95th percentile of the 2000 BMI-
for-age growth charts). 
Statistics released by the American Heart Association show that 
the rise in obesity correlates with high low-density lipoprotein-cho-
lesterol (LDL-C) levels. In 2004, nearly 33% of adults in the United 
States (age 20 and older) had LDL-C levels of 130 mg/dL or higher. 
Obesity is associated with disturbances in lipid metabolism including 
triglycerides, free fatty acids and lipoprotein cholesterol. One com-
mon finding in obese individuals is elevated levels of circulating free 
fatty acids that in turn increases fatty acid internalization and ecto-
pic accumulation of triglycerides. Such disturbances in normal lipid 
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metabolic homeostasis are associated with changes in fatty acid oxi-
dation, accumulation of reactive oxygen species, the synthesis of ce-
ramide and ER stress. The correlation between chronically elevated 
plasma free fatty acids and triglycerides and low highdensity lipopro-
tein-cholesterol (HDL-C) levels with the development of obesity, insu-
lin resistance and cardiovascular disease has led to the hypothesis that 
decreases in pancreatic insulin production, cardiac failure, arrhyth-
mias, and hypertrophy are due to aberrant accumulation of lipids in 
these tissues. This Special Issue of Immunology, Endocrine and Meta-
bolic Agents in Medicinal Chemistry, with a focus on dietary lipid ab-
sorption, is particularly timely given the obesity epidemic and comes 
from many of the leading experts in fatty acid and sterol transport. 
These review articles cover five general areas: [1] Fatty acid trans-
port, with a focus on fatty acid translocase (CD36) and members of 
the fatty acid transport protein (FATP) family; [2] sterol transport, 
with a focus on Niemann-Pick C1-Like 1 (NPC1L1) and ATP binding 
cassette transporters G5 and G8 (ABCG5/ABCG8); [3] intracellular 
fatty acid trafficking, with a specific focus on liver fatty acid binding 
protein (L-FABP); [4] therapeutic properties of n-3 polyunsaturated 
fatty acids; and [5] chylomicron synthesis with a focus on regulation 
and the role of apolipoproteins. 
Articles by Nassir and Abumrad and Black et al. summarize recent 
research into defining the molecular mechanisms involved in fatty 
acid transport, particularly at the level of the plasma membrane. Most 
of the data indicate this process consists of both diffusive and pro-
tein-mediated components. In the context of dietary lipid absorption, 
Nassir and Abumrad present a current view of fatty acid translocase 
(CD36), which is expressed in the proximal intestine and thought to 
function in coordinating absorption of fatty acids and cholesterol for 
optimal chylomicron formation and secretion. The article by Black 
et al. summarizes current our understanding of the fatty acid trans-
port protein (FATP) family members, which in some instances ap-
pear to associate with long chain acyl CoA synthetase (Acsl). One op-
erational strategy governing the transport of fatty acids proceeding 
through FATP and Acsl is vectorial acylation whereby fatty acids are 
transported and concomitantly activated to CoA thioesters for further 
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metabolism. As pointed out in these two articles, proteins involved in 
intestinal fatty acid transport, specifically CD36 and FATP, represent 
potentially important and accessible targets for the management of 
hyperlipidemia by reducing absorption of dietary lipid. Along these 
lines, high throughput strategies have been employed to select for 
small molecule inhibitors of FATP, but with caveat that disrupting fatty 
acid import of systemic trafficking pathways may have unfavorable 
consequences (ref Black et al.). The relatively high frequency of poly-
morphism in the CD36 gene and the corresponding high incidence of 
CD36 deficiency in some populations suggest this protein may con-
tribute to individual variations in lipid absorption and processing and 
thus like FATP may be an especially attractive drug target (ref Nassir 
and Abumrad). 
Brown and Yu review the current state of knowledge regarding the 
function of Niemann-Pick C1-Like 1 (NPC1L1) and ATP-binding cas-
sette transporters G5 and G8 (ABCG5/ABCG8), which represent op-
posing apical intestinal cholesterol transporters. NPC1L1 is essential 
for intestinal cholesterol absorption and protection against excessive 
biliary sterol loss while ABCG5/ABCG8 is critical for promoting bili-
ary cholesterol secretion in the liver and is likely to provide a direct 
role in intestinal disposal of sterols. Both NPC1L1 and ABCG5/ABCG6 
represent therapeutic targets aimed at reduction of circulating LDL-
C, which represent a major risk factor for the development of athero-
sclerotic cardiovascular disease. Of particular note is the compound 
ezetimibe currently in clinical use, which specifically targets NPC1L1 
and reduces intestinal cholesterol absorption. 
Intracellular fatty acid trafficking in liver and intestine is controlled 
in large part by fatty acid binding protein, L-FABP. As reviewed by 
Newberry and Davidson, of particular importance is the finding that 
members of the FABP multigene family serve as important metabolic 
sensors that regulate fatty acid trafficking and metabolic compartmen-
talization. Studies using L-Fabp–/– mice are consistent with the notion 
that L-FABP provides an important role in modulating hepatic fatty 
acid trafficking in response to augmented lipid mobilization from adi-
pose stores. The L-Fabp–/– mice are also protected against obesity and 
hepatic steatosis when fed a high saturated fat diet or a high saturated 
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fat diet containing cholesterol, but not when fed a high fat diet con-
taining polyunsaturated fat (ref Newberry and Davidson). These ob-
servations are of particular interest as they suggest the lipid sensing 
functions of L-FABP may, in part, be dependent upon specific fatty 
acid species. L-FABP appears to regulate processes in both intestinal 
and hepatic fatty acid trafficking through specific diet-gene interac-
tions thus providing an important link in the pathogenesis of diet-in-
duced obesity and hepatic steatosis. 
The articles by Kim et al. and Calder present current research find-
ings showing dietary n-3 polyunsaturated fatty acids (PUFA) exhibit 
anti-inflammatory bioactive properties, compared to n-6 PUFA. The 
n-6 PUFA arachidonic acid is the precursor of inflammatory eico-
sanoids including prostaglandin E2 and leukotriene B4. The n-3 PUFAs 
eicosapentaenoic acid and docosahexaenoic acid inhibit arachidonic 
acid metabolism to inflammatory eicosanoids and give rise to media-
tors that are antiinflammatory (ref Calder). As pointed out in the ar-
ticle by Kim et al. there are multiple mechanisms by which n-3 PUFAs 
exert these affects, particularly in the context of the immune cell re-
sponse. The putative targets of anti-inflammatory n-3 PUFAs include 
cytokine production, antagonism of n-6 PUFA metabolism, binding to 
nuclear receptors as ligands, and the alteration of signaling protein 
acylation. Work by Kim et al. has extended this further by showing 
n-3 PUFAs function in the coalescence of lipid rafts resulting in spe-
cialized signaling platforms at the plasma membrane. Given the anti-
inflammatory properties of n-3 PUFAs they may be of therapeutic use 
in a variety of acute and chronic inflammatory settings, including in-
flammatory bowel diseases and asthma, but it is clear that additional 
clinical trails are required (ref Calder). 
The final two articles by Ji et al. and Mansbach address the process 
formation of chylomicron formation s following fatty acid absorption, 
which includes and summarizes new findings in regarding the syn-
thesis and secretion of chylomicrons that distribute absorbed dietary 
lipid. Ji et al. describe the roles of the various lipid esterifying en-
zymes in the metabolism of the absorbed partial glycerides and fatty 
acids and detail the formation of chylomicrons and very low-density 
lipoprotein. The article by Mansbach provides additional information 
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detailing how triacylglycerol (TAG) crosses the endoplasmic reticu-
lum and is incorporated into the developing chylomicron through a 
two-step process involving apolipoprotein B48. In this latter article, 
there is discussion regarding the regulation of pre-chylomicron trans-
port vesicle generation through the action of PKCζ. Ji et al. point out 
in their article that a thorough understanding of combined processes 
involved in intestinal lipid absorption provides an invaluable frame-
work of information to address obesity and hyperlipidemia. 
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